Clinical Trial

Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. This study will investigate the study device, Livi, in a broader clinical setting.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06530186
Lead Sponsor Atlantic Health System
Conditions Vaginal Infection, Vaginal Discharge, Vaginosis, Sexual Dysfunction
Enrollment 1,000 participants
Start Date 2024-08-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-31